What does APOTHEEK VAN ACOLEYEN do?

APOTHEEK VAN ACOLEYEN is a pharmacy in Meise. Private Limited, started on 3 January 2008, 1 establishment.

What is the address of APOTHEEK VAN ACOLEYEN?

The registered office of APOTHEEK VAN ACOLEYEN is located at Gemeenteplein 1, 1861 Meise.

Is APOTHEEK VAN ACOLEYEN still active?

Yes. According to the CBE (30 October 2026) APOTHEEK VAN ACOLEYEN is active, legal situation “Normale toestand”, started on 3 January 2008.

Is APOTHEEK VAN ACOLEYEN registered on Peppol?

Yes, APOTHEEK VAN ACOLEYEN is registered on the Peppol network with ID 0208:0894625654.

What is the enterprise number of APOTHEEK VAN ACOLEYEN?

The enterprise number of APOTHEEK VAN ACOLEYEN is BE0894625654.

When was APOTHEEK VAN ACOLEYEN founded?

APOTHEEK VAN ACOLEYEN was founded on 3 January 2008.

Who are the directors of APOTHEEK VAN ACOLEYEN?

According to the 2025 annual accounts, the directors of APOTHEEK VAN ACOLEYEN are: EMVACO BV, Digix COMM V.

Is APOTHEEK VAN ACOLEYEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 January 2008; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK VAN ACOLEYEN make in 2025?

APOTHEEK VAN ACOLEYEN posted a profit after taxes of € 25,227 in financial year 2025.

What is the revenue of APOTHEEK VAN ACOLEYEN?

As a small company, APOTHEEK VAN ACOLEYEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 202,826.

How much does an employee at APOTHEEK VAN ACOLEYEN earn?

The average wage cost per full-time employee at APOTHEEK VAN ACOLEYEN was € 54,500 in 2025: staff costs of € 98,150 for 1.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK VAN ACOLEYEN have?

According to the 2025 annual accounts, APOTHEEK VAN ACOLEYEN has 1.8 full-time equivalents (FTE).

APOTHEEK VAN ACOLEYEN (Private Limited) - Meise

Dossier APOTHEEK VAN ACOLEYEN, printed on 30 October 2026 from databakkes.be/en/0894625654/apotheek-van-acoleyen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK VAN ACOLEYEN from Meise, company number BE0894625654, closed financial year 2025 with a result of € 25,227 after tax. For that financial year APOTHEEK VAN ACOLEYEN recorded a gross margin of € 202,826 and equity of € 485,175. Compared with financial year 2024, the result moved from € 52,142 to € 25,227. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.

What it is worth Growing

€ 485,175

▲ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 25,227

▼ 52% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 183,427

▲ 125% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 478,975.

People and assets in 2025

Full-time equivalents

1.8

▲ 1.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 98,150

▲ 109% vs 2024

€ 54,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 36,185

▼ 17% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 25 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 509,632

▼ 4% vs 2024

€ 20,064 is repaid this year. At this pace the long-term loan is gone in ≈ 25 years.

Owed to suppliers

€ 111,500

▲ 20% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 19,585

▲ 277% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 264,608 Gross margin 2022: € 264,608 First fiscal year in the series	€ 205,252 Gross margin 2023: € 205,252 ▼ 22% vs 2022 (€ 264,608) Unfavourable step	€ 167,085 Gross margin 2024: € 167,085 ▼ 19% vs 2023 (€ 205,252) Unfavourable step	€ 202,826 Gross margin 2025: € 202,826 ▲ 21% vs 2024 (€ 167,085) Favourable step	▲ 21%
Profit after taxes	€ 102,395 Profit after taxes 2022: € 102,395 First fiscal year in the series	€ 36,147 Profit after taxes 2023: € 36,147 ▼ 65% vs 2022 (€ 102,395) Unfavourable step	€ 52,142 Profit after taxes 2024: € 52,142 ▲ 44% vs 2023 (€ 36,147) Favourable step	€ 25,227 Profit after taxes 2025: € 25,227 ▼ 52% vs 2024 (€ 52,142) Unfavourable step	▼ 52%
Equity	€ 371,659 Equity 2022: € 371,659 First fiscal year in the series	€ 407,806 Equity 2023: € 407,806 ▲ 10% vs 2022 (€ 371,659) Favourable step	€ 459,948 Equity 2024: € 459,948 ▲ 13% vs 2023 (€ 407,806) Favourable step	€ 485,175 Equity 2025: € 485,175 ▲ 5% vs 2024 (€ 459,948) Favourable step	▲ 5%
Total debts	€ 397,565 Total debts 2022: € 397,565 First fiscal year in the series	€ 213,054 Total debts 2023: € 213,054 ▼ 46% vs 2022 (€ 397,565) Favourable step	€ 658,835 Total debts 2024: € 658,835 ▲ 209% vs 2023 (€ 213,054) Unfavourable step	€ 673,111 Total debts 2025: € 673,111 ▲ 2% vs 2024 (€ 658,835) Unfavourable step	▲ 2%
Cash	€ 239,680 Cash 2022: € 239,680 First fiscal year in the series	€ 260,916 Cash 2023: € 260,916 ▲ 9% vs 2022 (€ 239,680) Favourable step	€ 81,652 Cash 2024: € 81,652 ▼ 69% vs 2023 (€ 260,916) Unfavourable step	€ 183,427 Cash 2025: € 183,427 ▲ 125% vs 2024 (€ 81,652) Favourable step	▲ 125%
Land & buildings	-	-	€ 660,958 Land & buildings 2024: € 660,958 First fiscal year in the series	€ 644,558 Land & buildings 2025: € 644,558 ▼ 2% vs 2024 (€ 660,958) Unchanged	▼ 2%
Retained profit	€ 365,459 Retained profit 2022: € 365,459 First fiscal year in the series	€ 401,606 Retained profit 2023: € 401,606 ▲ 10% vs 2022 (€ 365,459) Favourable step	€ 453,748 Retained profit 2024: € 453,748 ▲ 13% vs 2023 (€ 401,606) Favourable step	€ 478,975 Retained profit 2025: € 478,975 ▲ 6% vs 2024 (€ 453,748) Favourable step	▲ 6%
Dividend	€ 147,700 Dividend 2022: € 147,700 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 147,700) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 529,007 Bank debt 2024: € 529,007 Unchanged (€ 0) Unfavourable step	€ 509,632 Bank debt 2025: € 509,632 ▼ 4% vs 2024 (€ 529,007) Favourable step	▼ 4%
Balance sheet total	€ 769,224 Balance sheet total 2022: € 769,224 First fiscal year in the series	€ 620,860 Balance sheet total 2023: € 620,860 ▼ 19% vs 2022 (€ 769,224) Unchanged	€ 1,118,783 Balance sheet total 2024: € 1,118,783 ▲ 80% vs 2023 (€ 620,860) Unchanged	€ 1,158,286 Balance sheet total 2025: € 1,158,286 ▲ 4% vs 2024 (€ 1,118,783) Unchanged	▲ 4%
Employees (FTE)	1.4 Employees (FTE) 2022: 1.4 First fiscal year in the series	1 Employees (FTE) 2023: 1 ▼ 0.4 vs 2022 (1.4) Unchanged	0.4 Employees (FTE) 2024: 0.4 ▼ 0.6 vs 2023 (1) Unchanged	1.8 Employees (FTE) 2025: 1.8 ▲ 1.4 vs 2024 (0.4) Unchanged	▲ 1.4

Key figures of APOTHEEK VAN ACOLEYEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK VAN ACOLEYEN?

What happened at APOTHEEK VAN ACOLEYEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 25, 2026 New annual accounts for financial year 2025: profit of € 25,227 (▼ 52% vs 2024). filed late Source: NBB ↗
2024 EMVACO BV became a director. NBB
2024 Digix COMM V became a director. NBB
Jan 3, 2008 New establishment in Meise. KBO
Jan 3, 2008 Start of the company according to the CBE. KBO

In short

From € 102,395 profit in 2022 to € 25,227 profit in 2025.

Paid € 71,588 in corporate taxes since 2022.

Best year ever: 2022, with € 102,395 profit.

On average € 112,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

EMVACO 60%

The stake of EMVACO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK VAN ACOLEYEN

Behind APOTHEEK VAN ACOLEYEN are EMVACO BV and Digix COMM V. The shares are held by EMVACO (60%).

Directors

According to the 2025 annual accounts

EMVACO BV

Director · represented by Van Acoleyen Emily

since 2024

Digix COMM V

Director · represented by Dierickx Jan

since 2024

Shareholders

EMVACO

60%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Gemeenteplein 1

1861 Meise

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0894.625.654
VAT number: BE 0894.625.654
Registered office: Gemeenteplein 1, 1861 Meise
Names & denominations: APOTHEEK VAN ACOLEYEN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 3 January 2008
Peppol: Active · Active since 8 Jan 2026
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗